The US Food and Drug Administration (FDA) has announced that Tandem Diabetes Care, Inc has issued a recall regarding version 2.7 of the Apple iOS t:connect mobile app that is used in conjunction with the t:slim X2 insulin pump, which uses Control-IQ technology. The recall, specifically referred to as a correction and not a product removal,…
Credit: Pixabay/CC0 Public Domain Pamela Collins’ journey to global mental health started on a bus in Haiti in 1987. Working for the first time in a predominantly Black country, the young medical student sometimes took public transportation and enjoyed blending into the majority. “What really struck me that summer was how important social context is…
A new study in Proceedings of the National Academy of Science discusses the role of the protein WASF3 in preventing ME/CFS patients from generating normal amounts of cellular energy. ME/CFS is a condition characterized by extreme fatigue and neurological concerns with no known cause. Research has shown that people with ME/CFS have high WASF3 levels…
Autism, a developmental disability that affects behavior, communication, and learning, is important to understand on World Autism Awareness Day. It affects 1% of children globally and can last a lifetime, with symptoms varying in severity. Genetics and certain risk factors like exposure to pollution or birth complications play a role. Signs of autism include social…
A dangerous bacterial infection known as streptococcal toxic shock syndrome (STSS) is on the rise in Japan, with a record high of 941 cases reported last year. This year, 378 cases have been reported in just the first two months of 2024. The infection, caused by the Strep A bacterium, can lead to severe tissue…
An antitrust lawsuit has been filed against Cigna-owned online pharmacy and pharmacy benefit manager (PBM) Express Scripts by several independent pharmacies. The lawsuit alleges that Express Scripts teamed with rival PBMs to fix pharmaceutical reimbursement rates and fees, resulting in collecting a portion of the revenue. PBMs negotiate prescription prices, which can be substantially higher…
After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment. Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional,…
National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next Gen Basketball Players Union (NBGPU) in collaboration with GE HealthCare and MedStar Health today announced the completion of the data collection phase of a longitudinal pilot study of NBA G League players. The research study was designed to collect data that could…
Scientists hope that C100 can be developed into an effective adjuvant for use in cancer therapies A new vaccine ‘booster’ may be able to trigger an immune response in tumours and open the door to the development of new cancer treatments. Scientists from Trinity College Dublin have discovered that a vaccine adjuvant – or ‘booster’…
Zoom dysmorphia is a negative perception of one’s body image exacerbated by frequent video calls, causing anxiety, self-esteem issues, and a desire for cosmetic procedures. Dr. George Kroumpouzos and colleagues proposed a screening tool to identify zoom dysmorphia, as no diagnostic criteria exist. The tool includes open-ended questions and specific inquiries related to concerns about…
